Tags

Type your tag names separated by a space and hit enter

Help Is on the Way: Medicare Coverage of Opioid Treatment Programs.

Abstract

Opioid use disorder (OUD) among older adults has been increasing, yet evidence still remains scarce for age-specific treatment. We discuss the three US Food and Drug Administration-approved medications used to treat OUD (methadone, buprenorphine, and naltrexone) and consider evidence gaps in OUD treatment in older adults. Legislation passed in 2018 (the Substance Use Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act [also known as the SUPPORT Act]) expanded Medicare coverage to include bundled payment for OUD treatment through opioid treatment programs, permitting coverage of methadone treatment for the first time. Since the policy change will take effect in January 2020, healthcare providers need to be aware of new opportunities for treatment when caring for older adult patients with OUD.

Authors+Show Affiliations

Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.Institutes for Behavior Resources/REACH Health Services, Baltimore, Maryland.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

31825528

Citation

Felix, Cynthia, et al. "Help Is On the Way: Medicare Coverage of Opioid Treatment Programs." Journal of the American Geriatrics Society, 2019.
Felix C, Sharfstein JM, Olsen Y. Help Is on the Way: Medicare Coverage of Opioid Treatment Programs. J Am Geriatr Soc. 2019.
Felix, C., Sharfstein, J. M., & Olsen, Y. (2019). Help Is on the Way: Medicare Coverage of Opioid Treatment Programs. Journal of the American Geriatrics Society, doi:10.1111/jgs.16281.
Felix C, Sharfstein JM, Olsen Y. Help Is On the Way: Medicare Coverage of Opioid Treatment Programs. J Am Geriatr Soc. 2019 Dec 11; PubMed PMID: 31825528.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Help Is on the Way: Medicare Coverage of Opioid Treatment Programs. AU - Felix,Cynthia, AU - Sharfstein,Joshua M, AU - Olsen,Yngvild, Y1 - 2019/12/11/ PY - 2019/08/18/received PY - 2019/11/08/revised PY - 2019/11/08/accepted PY - 2019/12/12/entrez PY - 2019/12/12/pubmed PY - 2019/12/12/medline KW - Medicare KW - Substance Use Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act (SUPPORT Act) KW - medications for addiction treatment KW - methadone KW - older adult KW - opioid addiction KW - opioid use disorder JF - Journal of the American Geriatrics Society JO - J Am Geriatr Soc N2 - Opioid use disorder (OUD) among older adults has been increasing, yet evidence still remains scarce for age-specific treatment. We discuss the three US Food and Drug Administration-approved medications used to treat OUD (methadone, buprenorphine, and naltrexone) and consider evidence gaps in OUD treatment in older adults. Legislation passed in 2018 (the Substance Use Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act [also known as the SUPPORT Act]) expanded Medicare coverage to include bundled payment for OUD treatment through opioid treatment programs, permitting coverage of methadone treatment for the first time. Since the policy change will take effect in January 2020, healthcare providers need to be aware of new opportunities for treatment when caring for older adult patients with OUD. SN - 1532-5415 UR - https://www.unboundmedicine.com/medline/citation/31825528/Help_Is_on_the_Way:_Medicare_Coverage_of_Opioid_Treatment_Programs L2 - https://doi.org/10.1111/jgs.16281 DB - PRIME DP - Unbound Medicine ER -